Health Resources and Services Administration: Affordable Care Act - Immediate Facility Improvements Program

by: Iola Bonggay
The Health Resources and Services Administration(HRSA), under the supervision of the Department of Health and Human Services, is the country's premier agency for citizens who are insured, isolated, or medically vulnerable.

In keeping with this purpose, the HRSA mainly focuses on administering health care grants to eligible individuals, in order to help them obtain safe and quality care. Which is why, the HRSA also offers training to health professionals in rural communities in high hopes of constantly improving their systems of care.

The HRSA has recently developed the competitive Affordable Care Act Capital Development - Immediate Facility Improvements program, which gives funding opportunities to existing grantees of the Health Center Program as they address immediate and pressing financial needs, such as alteration/renovation projects at an existing facility, installation of life safety requirements at an existing facility, associated work required to modernize, improve, and/or reconfigure the interior arrangements or other physical characteristics of a facility.

The Affordable Care Act Capital Development - Immediate Facility Improvements Program will award approximately $100 million to 250-300 existing eligible Health Center Program Grantees.  (continued...)

Health Resources and Services Administration: Affordable Care Act - Immediate Facility Improvements Program
  Page 2

About The Author

Additional Resources

category - Health Grants

Minor Use Minor Species Development of Drugs: Research Project Grant
The National Institutes of Health has partnered with the U.S. Food and Drug Administration (FDA) and the Center for Veterinary Medicine(CVM) in an effort to establish the Minor Use Minor Species Development of Drugs: Research Project Grant.

---

Core Clinical Centers for the Cardiothoracic Surgical Trials Network Program
In keeping with this mission, the National Institutes of Health has partnered with the Canadian Institutes of Health Research (CIHR), the National Heart, Lung, and Blood Institute (NHLBI), and the Institute of Circulatory and Respiratory Health (ICRH) to establish the Core Clinical Centers for the Cardiothoracic Surgical Trials Network Program.

---

Identifying Heart, Lung, and Blood Disease-Causing Variants
The National Institutes of Health has formed a partnership with the National Heart, Lung, and Blood Institute to establish a program that aims to Identify Heart, Lung, and Blood Disease-Causing Variants.

---

Development of Therapeutics and Diagnostics for Biodefense Program
The National Institutes of Health, in partnership with the National Institute of Allergy and Infectious Diseases(NIAID), has established the Development of Therapeutics and Diagnostics for Biodefense Program in an attempt to seek research proposals that desire to support the development of lead candidate diagnostics or therapeutics against NIAID Category A, B, or C priority agents.

---